| cannabis |
hyperemesis
in humans via review (n=18) |
Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review |
May 2019 |
|
Current data for capsaicin efficacy in CHS is of low methodological quality. However, the limited data on alternative antiemetic therapies and capsaicins favorable risk-benefit profile make it a reasonable adjunctive treatment option.
|
| cannabis |
hyperemesis
via review |
Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review |
May 2019 |
|
The presentation of cannabis hyperemesis may be atypical in palliative care patients due to disability. More work is needed to improve risk stratification for patients using cannabis for palliative care.
|
| cannabis |
hyperemesis
in humans via case study (n=1) |
Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome |
Jun 2019 |
|
We report a case study where aprepitant (Emend) was successfully used as an anti-emetic in the treatment of CHS when all other common anti-emetics failed.
|
| cannabis |
hyperemesis
in humans via review |
The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome |
Feb 2019 |
|
We reported the use of droperidol in the management of CHS. Droperidol treatment group median length of stay was significantly lower compared to the no droperidol treatment group (6.7 vs. 13.9 hours, p = .014). The most frequent dosage of droperidol used was 0.625mg intravenously.
|
| cannabis |
hyperemesis
via review |
Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting. |
Apr 2019 |
|
Although the definitive treatment of cannabinoid hyperemesis syndrome is discontinuing the causative agent, medical management that includes rehydration is important to prevent complications. Common antiemetic medications are ineffective, but some studies have shown haloperidol and lorazepam to be effective in treating acute symptoms.
|
| cannabis |
hyperemesis
in humans via study (n=4) |
Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series. |
Jun 2019 |
|
After excluding urgent gastrointestinal and CNS origins for the vomiting, we suspected CHS. All four patients experienced similar symptoms and failure of conventional treatment with antiemetics and proton pump inhibitors. They experienced relief after administration of benzodiazepines.
|